2004, Marketing, Ownership and Public Use - Intellectual Property Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2004

Marketing

Ownership

Public Use

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. Yet biosimilars of anti-TNF?

Settlement

Settlement Litigation Marketing Marketing

The US’ Review of March-in Rights, and Some Questions on an Indian Counterpart

SpicyIP

JANUARY 5, 2024

The ownership of the patent remains with the institute – it is only a right to licence to third parties which is accrued in favour of the government if it chooses to exercise this right. which requires patented products to be significantly manufactured in the US until it is commercially infeasible.

Invention

Invention Government Intellectual Property IP

Biosimilars 2020 Year in Review

The US’ Review of March-in Rights, and Some Questions on an Indian Counterpart

Stay Connected